BioSpace News Archive

Job Trends

Pharos Capital Recapitalizes Post-Acute Care Provider Charter Health Care Group

Forms New Platform Focused on Hospice, Home Health, and Transitional Care Services

October 30, 2018
·
3 min read
Biotech Bay

Livongo Introduces Applied Health Signals™

Combines Data Science, Behavior Enablement, and Clinical Impact to Reinvent the Chronic-Condition Experience

October 30, 2018
·
4 min read
Business

GC Pharma Reports Q3 2018 Results

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the three months ended September 30, 2018.

October 30, 2018
·
1 min read
Business

UCB First Nine Months Interim Report 2018: UCB tracking well towards full year financial outlook

- Revenue reached € 3.4 billion (+3%; +6% CER)

October 30, 2018
·
9 min read
Job Trends

Positive Preclinical Findings from Inhaled NanoPac® Lung Study Published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery

Preclinical Study Demonstrated Inhaled NanoPac Shows Prolonged Retention and Limited Systemic Exposure

October 30, 2018
·
3 min read
Business

Cyrus Biotechnology and OpenEye Scientific Software Announce Collaboration and Cheminformatics Integration to Expedite New Drug Design and Development with Cyrus Bench Platform

Cyrus Biotechnology, Inc. announced today that through a collaboration with OpenEye Scientific Software, Inc., a leader in computational molecular design, capabilities have been developed that allow small molecule ligands to be processed and used with Rosetta and within the Cyrus Bench® platform for computational protein drug design.

October 30, 2018
·
4 min read
Business

WellCare Reports Third Quarter 2018 Results

COMPANY INCREASES FULL-YEAR 2018 GUIDANCE

October 30, 2018
·
34 min read
Policy

U.S. Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR/Cas9 Gene Editing

The patent covers compositions of both single and dual guide RNAs in all environments including use in human and animal cells.

October 30, 2018
·
1 min read
Business

Bio-Techne Declares Dividend Payable November 23, 2018

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2018.

October 30, 2018
·
1 min read
Business

Blue Cross Blue Shield Of Massachusetts And South Shore Health System Launch Groundbreaking Pilot Program To Improve Patient Care And Lower Health Care Costs

Global budget payment model provides financial incentives for improving community health and reducing costs

October 30, 2018
·
6 min read